Biotech
-
Lixte’s Big Bet: Making Other Cancer Drugs Work Harder
Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT) is a Nasdaq-listed biotech with an unusually focused story: one main drug,…
-
InvestorTalk Alert: Andre Larente from Diagnos Inc. to host on Tuesday, October 7, 2025
InvestorNews.com is pleased to announce an upcoming InvestorTalk scheduled for tomorrow, Tuesday, October 7, at 9 AM EST,…
-
Cardiol Therapeutics’ Cannabidiol Formulation Reduced Inflammation—Phase II Topline Data Ignites the Race to Treat Acute Myocarditis
A single‐digit p-value has rarely carried such freight. Cardiol Therapeutics Inc. (NASDAQ: CRDL | TSX: CRDL) this morning unveiled…
-
Zentek CEO Greg Fenton on Revolutionizing Graphite Purity and Commercializing Breakthrough Filtration Technology
March 19, 2025 — Zentek Ltd. (NASDAQ: ZTEK | TSXV: ZEN) is poised to revolutionize the graphite and…
